Sterling Investment Advisors, Ltd. - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 116 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2017. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
Sterling Investment Advisors, Ltd. ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q2 2019$0
-100.0%
2500.0%0.00%
-100.0%
Q1 2019$1,0002500.0%0.00%
Q4 2018$0
-100.0%
2500.0%0.00%
-100.0%
Q3 2018$3,000
+200.0%
2500.0%0.00%
+100.0%
Q2 2018$1,000
-50.0%
2500.0%0.00%0.0%
Q1 2018$2,0000.0%2500.0%0.00%0.0%
Q4 2017$2,000
-95.5%
250
-95.0%
0.00%
-96.6%
Q3 2017$44,0005,0000.03%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2017
NameSharesValueWeighting ↓
ADVANTAGE INVESTMENT MANAGEMENT, LLC 105$00.00%
Sterling Investment Advisors, Ltd. 250$00.00%
Front Row Advisors LLC 60$00.00%
Executive Wealth Management, LLC 20$00.00%
BARCLAYS PLC 1,300$00.00%
BARCLAYS PLC 33,172$10,0000.00%
HUNTINGTON NATIONAL BANK 1$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Financial Gravity Asset Management, Inc. 50$00.00%
Vectors Research Management, LLC 505$00.00%
View complete list of INSYS THERAPEUTICS INC NEW shareholders